Market review: two weeks after February, the CSI 300 index fell 0.4%, the gem index rose 2.3%, and the Wande medical beauty industry index rose 0.8%, which is between the CSI 300 and the gem index.
Important information about the medical and beauty industry: (1) industry self-discipline: the 39th meeting of the Standing Committee of the 15th Shanghai Municipal People’s Congress voted to adopt the newly revised regulations of Shanghai Municipality on the protection of minors. The regulations specify that no organization or individual shall illegally engage in transactions with minors that are incompatible with the age and intelligence of minors, and shall not provide tattoo services to minors; No medical beauty service shall be provided to minors without the consent of their parents or other guardians. The regulation came into effect on March 1. (2) Industry news: Meibai, a medical beauty platform, has signed a strategic cooperation agreement with langzi medical beauty. The two sides will deepen strategic cooperation in six aspects: business mutual assistance, information sharing, talent training, brand construction, the creation of medical beauty industry standards and the development of medical beauty new track. Meibai medical beauty is one of China’s two major Internet Medical Beauty platforms.
Important announcements of listed companies related to medical beauty: (1) Bloomage Biotechnology Corporation Limited(688363) : the company disclosed the performance express, and the company’s operating revenue in 2021 was 4.948 billion yuan, a year-on-year increase of 87.93%; The net profit attributable to the parent company was 782 million yuan, a year-on-year increase of 21.13%; The basic earnings per share is 1.63 yuan. (2) Shanghai Haohai Biological Technology Co.Ltd(688366) : the company issued a performance express. In 2021, the company’s operating revenue was 1.766 billion yuan, a year-on-year increase of 32.57%; The net profit attributable to the shareholders of the parent company was 352 million yuan, a year-on-year increase of 53.19%; The basic earnings per share is 2.00 yuan.
The newly revised “Regulations of Shanghai Municipality on the protection of minors” clearly stipulates that medical and beauty services shall not be provided to minors without the consent of their parents or other guardians, resist the “younger age of medical and beauty” in accordance with the law, and further standardize the chaos of the market. We believe that in the medium and long term, strengthening supervision is conducive to the healthy and orderly development of the industry, as well as the head, formal medical and American institutions and upstream raw material enterprises, and the listed companies (the A-share IPO of medical and American service related companies is expected to face greater challenges in the future). It is suggested to pay attention to upstream enterprises with good historical profitability and R & D certification ability, including Imeik Technology Development Co.Ltd(300896) ( Imeik Technology Development Co.Ltd(300896) , buy), Bloomage Biotechnology Corporation Limited(688363) ( Bloomage Biotechnology Corporation Limited(688363) , not rated), Shanghai Haohai Biological Technology Co.Ltd(688366) ( Shanghai Haohai Biological Technology Co.Ltd(688366) , not rated), etc.
Risk tip: increased competition, new product launch is less than expected, industry policy changes, etc.
